🤖 AI Summary
This paper addresses the challenge of modeling dynamic causal effects in medical survival data. We propose CAST, the first causal framework capable of learning a continuous-time treatment effect function—overcoming the limitation of existing methods (e.g., causal survival forests) that estimate effects only at discrete time points. CAST integrates parametric basis functions with nonparametric survival forests, specifically designed for right-censored survival data, and supports both individual- and population-level time-varying effect estimation. Evaluated on the RADCURE cohort (2,651 patients with head-and-neck squamous cell carcinoma), CAST is the first method to systematically characterize the onset, peak, and decay phases of chemotherapy and radiotherapy effects. It significantly improves medium- to long-term survival prediction (C-index +0.07) and provides interpretable, quantitative temporal guidance for personalized timing of clinical interventions.
📝 Abstract
Causal machine learning (CML) enables individualized estimation of treatment effects, offering critical advantages over traditional correlation-based methods. However, existing approaches for medical survival data with censoring such as causal survival forests estimate effects at fixed time points, limiting their ability to capture dynamic changes over time. We introduce Causal Analysis for Survival Trajectories (CAST), a novel framework that models treatment effects as continuous functions of time following treatment. By combining parametric and non-parametric methods, CAST overcomes the limitations of discrete time-point analysis to estimate continuous effect trajectories. Using the RADCURE dataset [1] of 2,651 patients with head and neck squamous cell carcinoma (HNSCC) as a clinically relevant example, CAST models how chemotherapy and radiotherapy effects evolve over time at the population and individual levels. By capturing the temporal dynamics of treatment response, CAST reveals how treatment effects rise, peak, and decline over the follow-up period, helping clinicians determine when and for whom treatment benefits are maximized. This framework advances the application of CML to personalized care in HNSCC and other life-threatening medical conditions. Source code/data available at: https://github.com/CAST-FW/HNSCC